NCT07217899View on ClinicalTrials.gov

Prophylactic Intravenous Calcium Gluconate to Decrease Blood Loss at Time of Cesarean Delivery in Pregnant Patients at High Risk for Uterine Atony

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

October 15, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

August 31, 2026

Conditions
Blood Loss, SurgicalBlood Loss, PostoperativeUterine Atony
Interventions
DRUG

Calcium Gluconate

slow push intravenous administration of 2g calcium gluconate- 20 mL of 10% Calcium Gluconate in 55mL of IV fluid diluent, Normal Saline CaGluc concentration 26.7 mg/mL

OTHER

Saline

slow push intravenous administration of 75 mL of IV

Trial Locations (1)

48109

University of Michigan, Ann Arbor

All Listed Sponsors
lead

University of Michigan

OTHER